By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...

Prostate health is vital for men over fifty as conditions like BPH, prostatitis, and cancer can affect urinary function and ...

When it comes to treatment for prostate cancer, men have a range of options, from active surveillance to radiation to surgery, just to name a few. Which approach to choose is a highly personal ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

Original Medicare (parts A and B) covers medically necessary prostate surgeries, including treatments for an enlarged prostate and prostate cancer. Medicare covers various prostate procedures, ...

High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and ...

Chris Gasper, a columnist for the Boston Globe and radio host with 98.5 The Sports Hub, said Tuesday that he’ll be taking ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...